As America’s first eye specialty hospital, founded in 1820, the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai (NYEE) is one of the world’s leading facilities for the most advanced surgical and micro-interventional procedures, as well as the latest diagnostic and therapeutic services aimed at delivering sight-saving interventions, safely and quickly. In addition to being at the forefront of innovative surgical specialty care, NYEE is home to the largest residency program in the US and also serves as the clinical site for breakthrough translational research with a network of satellite practices across the New York metropolitan area. NYEE is designated a “High-Performing” Hospital for Ophthalmology in the nation by U.S. News & World Report® for 2023-24.

Find us here: https://www.nyee.edu/care/eye/locations, or call 212-979-4500.

The Department of Rehabilitation and Human Performance at The Mount Sinai Hospital is dedicated to advancing human performance and solving barriers for those with disabilities. From sprains and strains to severe injuries affecting the spinal cord and brain, our specialists provide the highest level of evidence-based care.

The Mount Sinai Hospital's Rehabilitation department was ranked among the top 20 in the nation by U.S. News & World Report® for 2023-24. We offer comprehensive and coordinated services in both inpatient and outpatient settings. Our outpatient physician services are focused on rehabilitation medicine and interventional spine and sports medicine, with therapies offered by an interdisciplinary team, including neuropsychology, physical and occupational therapy, speech and language pathology, and vocational counseling.

Mount Sinai’s Abilities Research Center (ARC) offers innovative and individualized therapy designed to achieve the highest possible level of function. The ARC draws on the work of our research program to offer the newest available technologies to our patients. With the introduction of new technologies, innovation, and policy reform, the landscape of health care is always changing. What is constant is our desire to improve the human condition.

The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of the Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.

As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.

The Department of Urology at The Mount Sinai Hospital is ranked No. 18 in the nation by U.S. News & World Report® for 2023-24.

At Mount Sinai’s Brookdale Department of Geriatrics and Palliative Medicine, we are dedicated to improving the quality of life for older adults, persons with serious illness, and their loved ones. Our groundbreaking work has gained national recognition. The Mount Sinai Hospital is ranked No. 1 in Geriatrics in the nation for the fourth year in a row by U.S. News & World Report® for 2023-24, and we are nationally recognized as pioneers in palliative care. Under the leadership of R. Sean Morrison, MD, the Brookdale Department’s Ellen and Howard C. Katz Chair, our expert specialists provide clinical services and programs that encourage healthy aging, treat patients with serious illnesses, and provide support and education for family members and caregivers.

In addition to traditional medical treatments, we offer holistic and integrative health therapies to help strengthen patients' minds and bodies. We are also building sustainable models for practice, business, education, and research that can be used around the world to care for our aging population.

We understand that managing multiple conditions can often be complex. Our team of physicians, nurses, and social workers collaborates with other medical specialists to develop a comprehensive treatment plan and maintain the physical and emotional well-being of both patients and their loved ones in the setting that is most appropriate to their needs. We care for patients in the hospital, in the community, and in their homes.

Learn about the latest advances in diabetes and other endocrine disorders from the expert of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.

The Endocrinology, Diabetes and Bone Disease Division at the Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2023-24.

Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Mount Sinai physician Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD and other gastrointestinal disorders. Bruce Sands, MD, MS is the Chief of the Division of Gastroenterology and Director of the Digestive Disease Institute. A longtime advocate for the continued translational research in Crohn's disease and ulcerative colitis, Dr. Sands is widely recognized for his innovative treatment of IBD and for his clinical investigations of new therapeutics. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have advanced patient care. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.

The Gastroenterology & GI Surgery Division at the Mount Sinai Hospital is ranked No. 6 in the nation by U.S. News & World Report® for 2023-24.

Gain valuable insights from The Tisch Cancer Institute at Mount Sinai—a National Cancer Institute-designated cancer center and an integral part of the Mount Sinai Tisch Cancer Center—and cancer specialists throughout the Mount Sinai Health System. Our extensive network spans cancer prevention, innovative developments in precision-medicine and immunotherapy approaches, novel treatments via clinical trials, equity in cancer care, and groundbreaking translational research.

Under the leadership of Ramon Parsons, MD, PhD, Joseph A. Sparano, MD, and Luis Isola, MD, our comprehensive cancer program is renowned for its powerful synergy between research scientists and clinicians and its multidisciplinary scope. The Mount Sinai Hospital's Department of Oncology is ranked No. 12 in the nation by U.S. News & World Report® for 2023-24.

Under the leadership of Joshua B. Bederson, MD, Professor and Chair of Neurosurgery, Mount Sinai Health System is an internationally recognized leader in neurosurgery and continues to make a lasting global impact on neurosurgical outcomes, research, and education. As the largest unified and integrated neurosurgery department in New York City—with services provided throughout Manhattan, Queens, and Long Island—we provide more New Yorkers with neurosurgery care than any other health system in the city.

Mount Sinai’s Department of Neurosurgery is at the forefront of the rapid transformation of clinical practice driven by stunning new advances in technology and groundbreaking research. With Neurology and Neurosurgery at The Mount Sinai Hospital being ranked No. 9 in the nation by U.S. News & World Report® for 2023-24, Mount Sinai aims to educate clinicians on the treatment of patients’ challenging conditions with the insight and expertise of its world-renowned surgeons. And Mount Sinai Morningside/Mount Sinai West is ranked No. 28 in the nation for Neurology and Neurosurgery by U.S. News & World Report® for 2023-24.

Led by Barbara Vickrey, MD, MPH, Professor and Chair, the Department of Neurology at the Icahn School of Medicine at Mount Sinai is equally robust in patient care, education, and research. The Department's foundational mission includes training the next generation of clinicians, clinician-educators, clinician-investigators, and future leaders in medicine, as well as providing high-quality patient care to all New York City communities. A unique blend of personalized patient care integrated with groundbreaking research teams and technology is instrumental in the pursuit of improving outcomes in the treatment of Parkinson’s disease, epilepsy, multiple sclerosis, stroke, Alzheimer’s disease, and many other neurological disorders, referred from within our expansive health system, as well as from around the world.

Learn how The Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai is advancing women’s health care through innovative research, excellence in patient care, and our commitment to global and public health initiatives. Under the leadership of Joanne Stone, MD, MS, our nationally renowned experts are transforming the delivery of women’s health care at every stage of life and preparing our next generation of leaders.

Our Blavatnik Family Women’s Health Research Institute at Mount Sinai, under the direction of Leslee Shaw, PhD, is further working to optimize the delivery of care through impactful research that spans the life course—from pregnancy complications to chronic illness to gynecologic cancers—with the goal of improving the lives of all women.

The Department of Obstetrics and Gynecology at The Mount Sinai Hospital is ranked No. 11 in the nation by U.S. News & World Report® for 2023-24.

Learn about the groundbreaking cardiovascular care offered at the Mount Sinai Health System. Mount Sinai Heart at The Mount Sinai Hospital is ranked No. 4 in the nation for Cardiology and Cardiovascular Surgery by U.S. News & World Report® for 2023-24, and is recognized internationally as a leader in advancing all aspects of cardiology care, cardiac surgery, and cardiovascular research. Under the leadership of Valentín Fuster, MD, PhD, Deepak L. Bhatt, MD, MPH, David H. Adams, MD, and Samin K. Sharma, MD, our team of award-winning physicians is expanding the field of knowledge in cardiovascular medicine, including treatments for arrhythmias, coronary artery disease, heart failure, valvular disease, and vascular disease.

The Department of Orthopedic Surgery at Mount Sinai is at the forefront of minimally invasive orthopedic surgery and groundbreaking research. Under the leadership of Leesa M. Galatz, MD, Chair of Orthopedic Surgery at Mount Sinai Health System, our specialists use innovative medical and surgical solutions to treat all aspects of orthopedics, from common injuries to major reconstructive surgery.

The Department of Orthopedic Surgery at The Mount Sinai Hospital is ranked No. 11 in the nation by U.S. News & World Report® for 2023-24. We welcome you to meet our team and learn more about the advances in orthopedics at Mount Sinai.

Referring a patient is easy: Call 1-877-MD-ORTHO (1-877-636-7846) or email orthopedics@mountsinai.org

The Department of Otolaryngology – Head and Neck Surgery at Mount Sinai demonstrates excellence in all facets of clinical care, education and research. The Head and Neck Institute, Ear Institute at New York Eye and Ear Infirmary of Mount Sinai and Grabscheid Voice and Swallowing Center are internationally recognized for innovations and advancements in otolaryngology. Some examples include the first robotic surgery for oropharyngeal cancers in New York, the first donor tracheal transplant in the world, endoscopic surgery for otologic tumors, and transgender voice care. The Head and Neck Cancer Research Program has been in existence for more than 20 years, and offers a wide array of clinical trials. Our faculty are also recognized leaders in skull base and sinus surgery, as well as microvascular reconstruction. They provide the highest level of multidisciplinary care, and embrace their teaching role and participation in research.

The Department of Otolaryngology – Head and Neck Surgery at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2023-24.